Strategies for typhoid conjugate vaccines in endemic nations – authors' reply by Pitzer, VE, Pollard, AJ, Bilcke, J

Cost-effectiveness of typhoid conjugate vaccine strategies in 54 gavi-eligible countries by Bilcke, J, Antillon, M, Pieters, Z, Kuylen, E, Paltiel, A, Neuzil, K, Pollard, A, Pitzer, V

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study by Bilcke, J, Antillón, M, Pieters, Z, Kuylen, E, Abboud, L, Neuzil, K, Pollard, A, Paltiel, A, Pitzer, V

Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study by Birger, R, Antillón, M, Bilcke, J, Dolecek, C, Dougan, G, Pollard, AJ, Neuzil, KM, Frost, I, Laxminarayan, R, Pitzer, VE

Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: a multi-country prospective cohort study in Europe by Mao, Z, Li, X, Dacosta-Urbieta, A, Billard, M-N, Wildenbeest, J, Korsten, K, Martinón-Torres, F, Heikkinen, T, Cunningham, S, Snape, MD, Robinson, H, Pollard, AJ, Postma, M, Dervaux, B, Hens, N, Bont, L, Bilcke, J, Beutels, P

Direct and indirect costs of influenza-like illness treated with and without oseltamivir in 15 European countries: a descriptive analysis alongside the randomised controlled ALIC4E... by Li, X, Bilcke, J, van der Velden, AW, Bongard, E, Bruyndonckx, R, Sundvall, P-D, Harbin, NJ, Coenen, S, Francis, N, Bruno, P, Garcia-Sangenis, A, Glinz, D, Kosiek, K, Mikó-Pauer, R, Radzeviciene Jurgute, R, Seifert, B, Tsakountakis, N, Aabenhus, R, Butler, CC, Beutels, P